A phase I trial of LX 4211 in healthy volunteers.

Trial Profile

A phase I trial of LX 4211 in healthy volunteers.

Phase of Trial: Phase I

Latest Information Update: 15 Sep 2009

At a glance

  • Drugs Sotagliflozin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 15 Sep 2009 Status changed from recruiting to completed; reported by Lexicon in a media release.
    • 11 Dec 2008 New trial record.
    • 01 Dec 2008 Investigational New Drug Application submitted.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top